Drugs / IgHy10
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02881437 | Nov 2016 → Mar 2018 | immunodeficiency disease | University Hospital, Lille | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IgHy10 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02881437 ↗ |
| Route | Subcutaneous | “Sub Cutaneous IgHy10 administration” NCT02881437 ↗ |